跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 128 条关于
“Kyowa Hakko Kirin”
全部
128
临床试验
14
药物
30
机构
27
资讯
57
去年
Kyowa Hakko Kirin Partners with InveniAI to Accelerate Drug Repurposing Using AI Technology
7年前
Merck KGaA Partners with Iktos to Accelerate Drug Discovery Through AI-Powered Molecular Design
7个月前
Kyowa Kirin Regains Control of Rocatinlimab Development Following Amgen Partnership Termination
去年
Ziftomenib Shows Promise in AML: Kura Oncology and Kyowa Kirin Advance to Phase 3 Trials
去年
Kura Oncology and Kyowa Kirin Collaborate to Advance Ziftomenib for AML Treatment
去年
Mogamulizumab Shows Sustained Effectiveness in Real-World CTCL Studies
11个月前
Kyowa Kirin Stock Shows Mixed Valuation Signals Following Recent FDA Approval and Market Recovery
去年
Kyowa Kirin to Present Phase 3 Rocatinlimab Results for Atopic Dermatitis at EADV 2025
去年
Kura Oncology and Kyowa Kirin Partner to Advance Ziftomenib for Acute Leukemias
10个月前
Boehringer Ingelheim Licenses First-in-Class Small Molecule from Kyowa Kirin for Autoimmune Disease Treatment
第 1 页,共 6 页
上一页
下一页